Insider · CIK 0001231589

MAHON PAUL A

Reports to the SEC for 1 company · SILVER SPRING, MD

sec.gov

Transactions

Companies

Filings

CIK

0001231589

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-15	UTHRUNITED THERAPEUTICS CorpM Exercise/Conversion	EVP & GENERAL COUNSEL	MExercise/Conversion	+8,300 sh	$146.03	+$1.21M	53,472
2026-10-15	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−268 sh	$541.64	−$145K	53,204
2026-10-15	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−1,924 sh	$542.49	−$1.04M	51,280
2026-10-15	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−1,983 sh	$543.56	−$1.08M	49,297
2026-10-15	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−791 sh	$544.85	−$431K	48,506
2026-10-15	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−2,615 sh	$545.69	−$1.43M	45,891
2026-10-15	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−719 sh	$546.56	−$393K	45,172
2026-10-15	UTHRUNITED THERAPEUTICS Corp · Stock OptionM Exercise/Conversion	EVP & GENERAL COUNSEL	MExercise/Conversion	−8,300 sh	—	—	30,940
2026-10-01	UTHRUNITED THERAPEUTICS CorpM Exercise/Conversion	EVP & GENERAL COUNSEL	MExercise/Conversion	+8,300 sh	$146.03	+$1.21M	53,472
2026-10-01	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−880 sh	$558.30	−$491K	52,592
2026-10-01	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−1,480 sh	$560.19	−$829K	51,112
2026-10-01	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−780 sh	$561.87	−$438K	50,332
2026-10-01	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−1,480 sh	$563.09	−$833K	48,852
2026-10-01	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−400 sh	$566.41	−$227K	48,452
2026-10-01	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−720 sh	$567.76	−$409K	47,732
2026-10-01	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−739 sh	$569.15	−$421K	46,993
2026-10-01	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−838 sh	$570.90	−$478K	46,155
2026-10-01	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−823 sh	$572.25	−$471K	45,332
2026-10-01	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−160 sh	$573.15	−$91.7K	45,172
2026-10-01	UTHRUNITED THERAPEUTICS Corp · Stock OptionM Exercise/Conversion	EVP & GENERAL COUNSEL	MExercise/Conversion	−8,300 sh	—	—	39,240
2026-09-17	UTHRUNITED THERAPEUTICS CorpM Exercise/Conversion	EVP & GENERAL COUNSEL	MExercise/Conversion	+8,300 sh	$146.03	+$1.21M	53,472
2026-09-17	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−1,579 sh	$495.97	−$783K	51,893
2026-09-17	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−2,873 sh	$496.58	−$1.43M	49,020
2026-09-17	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−1,400 sh	$497.54	−$697K	47,620
2026-09-17	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−843 sh	$498.74	−$420K	46,777
2026-09-17	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−1,160 sh	$499.75	−$580K	45,617
2026-09-17	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−125 sh	$500.80	−$62.6K	45,492
2026-09-17	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−320 sh	$501.58	−$161K	45,172
2026-09-17	UTHRUNITED THERAPEUTICS Corp · Stock OptionM Exercise/Conversion	EVP & GENERAL COUNSEL	MExercise/Conversion	−8,300 sh	—	—	47,540
2026-09-03	UTHRUNITED THERAPEUTICS CorpM Exercise/Conversion	EVP & GENERAL COUNSEL	MExercise/Conversion	+8,300 sh	$146.03	+$1.21M	53,472
2026-09-03	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−1,545 sh	$478.93	−$740K	51,927
2026-09-03	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−936 sh	$479.66	−$449K	50,991
2026-09-03	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−2,360 sh	$480.86	−$1.13M	48,631
2026-09-03	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−1,048 sh	$481.92	−$505K	47,583
2026-09-03	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−160 sh	$482.66	−$77.2K	47,423
2026-09-03	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−200 sh	$483.85	−$96.8K	47,223
2026-09-03	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−954 sh	$485.12	−$463K	46,269
2026-09-03	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−598 sh	$486.47	−$291K	45,671
2026-09-03	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−169 sh	$487.36	−$82.4K	45,502
2026-09-03	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−10 sh	$488.32	−$4,883.2	45,492
2026-09-03	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−320 sh	$490.88	−$157K	45,172
2026-09-03	UTHRUNITED THERAPEUTICS Corp · Stock OptionM Exercise/Conversion	EVP & GENERAL COUNSEL	MExercise/Conversion	−8,300 sh	—	—	55,840
2026-08-20	UTHRUNITED THERAPEUTICS CorpM Exercise/Conversion	EVP & GENERAL COUNSEL	MExercise/Conversion	+2,690 sh	$146.03	+$393K	47,862
2026-08-20	UTHRUNITED THERAPEUTICS CorpM Exercise/Conversion	EVP & GENERAL COUNSEL	MExercise/Conversion	+5,610 sh	$146.03	+$819K	53,472
2026-08-20	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−2,690 sh	$524.15	−$1.41M	50,782
2026-08-20	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−502 sh	$520.03	−$261K	50,280
2026-08-20	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−1,819 sh	$521.04	−$948K	48,461
2026-08-20	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−787 sh	$522.00	−$411K	47,674
2026-08-20	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−850 sh	$522.78	−$444K	46,824
2026-08-20	UTHRUNITED THERAPEUTICS CorpS Sale	EVP & GENERAL COUNSEL	SSale	−192 sh	$523.69	−$101K	46,632

Recent filings

Accepted (ET)
Oct 164
MAHON PAUL A0001231589-26-000022
SEC(opens sec.gov)
Oct 14
MAHON PAUL A0001231589-26-000021
SEC(opens sec.gov)

Companies

UNITED THERAPEUTICS CorpEVP & GENERAL COUNSELUTHR

Address

C/O UNITED THERAPEUTICS CORPORATION 1000 SPRING STREET

SILVER SPRING, MD, 20910